Literature DB >> 28274741

A systemic evaluation of drug in acrylic pressure sensitive adhesive patch in vitro and in vivo: The roles of intermolecular interaction and adhesive mobility variation in drug controlled release.

Chao Liu1, Peng Quan1, Shanshan Li2, Yongshan Zhao3, Liang Fang4.   

Abstract

Though acrylic pressure sensitive adhesives (PSAs) are widely used in transdermal drug delivery system, molecular details of drug-PSA interactions, PSA molecular mobility variations and their influences on drug skin permeation are unclear. In this study, three classes of acrylic PSAs containing hydroxyl (AAOH), carboxyl (AACOOH) and non-functional group (AAnone) were synthesized. Their abilities of controlling drug release were evaluated using propranolol (PRO) and zaltoprofen (ZAL) in vitro and in vivo. Interaction details were identified by FT-IR, solid-state NMR and molecular modeling. Thermodynamic activity of drug and strength of drug-PSA interaction were characterized using miscibility study. PSA mobility was characterized using thermal analysis and rheology study. Thus, ionic interaction reduced the thermodynamic activity of PRO and mobility of AACOOH, which made PRO-AACOOH obtain a significant lower bioavailability (11.8±0.7%) than these of PRO-AAnone (40.7±2.5%) and PRO-AAOH (42.3±2.9%). Though thermodynamic activity of ZAL in AACOOH was lower than that in AAOH due to the hydrogen bonding, bioavailability of ZAL-AAOH (19.0±4.1%) exhibited no significant difference with ZAL-AACOOH (15.4±2.8%), mainly because AAOH mobility was decreased by ZAL. In conclusion, the strength, types and involved functional groups of drug-PSA interactions were identified. On this basis, it was found that different control patterns of drug release were not only caused by the thermodynamic or kinetic hindrance effects of drug-PSA interactions, but also influenced by the interactions introduced PSA mobility variations, which was an innovative mechanism of controlled release in transdermal patch. The conclusions extended our understanding about the mechanism of controlled drug release of drug-in-adhesive patch. In addition, they contributed to the design of TDDS and custom acrylic PSAs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adhesive mobility; Drug-in-adhesive patch; Intermolecular interaction; Pressure sensitive adhesives; Transdermal drug delivery system

Mesh:

Substances:

Year:  2017        PMID: 28274741     DOI: 10.1016/j.jconrel.2017.03.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

1.  Poly(Acrylic Acid)-Modified MoS2 Nanoparticle-Based Transdermal Delivery of Atenolol.

Authors:  Kai Zhang; Yanling Zhuang; Jiwen Li; Xiaochang Liu; Shaoheng He
Journal:  Int J Nanomedicine       Date:  2020-08-04

2.  Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4.

Authors:  Xianglei Fu; Yanbin Shi; Hui Wang; Xiaogang Zhao; Qifeng Sun; Yi Huang; Tongtong Qi; Guimei Lin
Journal:  Int J Nanomedicine       Date:  2019-11-27

3.  Quantitative Structure-Activity Relationship of Enhancers of Licochalcone A and Glabridin Release and Permeation Enhancement from Carbomer Hydrogel.

Authors:  Zhuxian Wang; Yaqi Xue; Zhaoming Zhu; Yi Hu; Quanfu Zeng; Yufan Wu; Yuan Wang; Chunyan Shen; Cuiping Jiang; Li Liu; Hongxia Zhu; Qiang Liu
Journal:  Pharmaceutics       Date:  2022-01-22       Impact factor: 6.321

4.  The enhancing effect and promoting mechanisms of the stereoisomeric monoterpene alcohol esters as enhancers for drugs with different physicochemical properties.

Authors:  Heping Wang; Yan Li; Chunyan Wang; Jing Wang; Bo Ren; Xiaona Li; Mingzhu Li; Dandan Geng; Chensi Wu; Ligang Zhao
Journal:  Asian J Pharm Sci       Date:  2021-12-09       Impact factor: 6.598

5.  Mechanistic insights of the controlled release capacity of polar functional group in transdermal drug delivery system: the relationship of hydrogen bonding strength and controlled release capacity.

Authors:  Zheng Luo; Chao Liu; Peng Quan; Degong Yang; Hanqing Zhao; Xiaocao Wan; Liang Fang
Journal:  Acta Pharm Sin B       Date:  2019-11-29       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.